Filing Details
- Accession Number:
- 0001104659-24-090603
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-16 19:08:23
- Reporting Period:
- 2024-08-14
- Accepted Time:
- 2024-08-16 19:08:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1823144 | Composecure Inc. | CMPO | Finance Services (6199) | 852749902 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1885801 | Joseph Adam Lowe | C/O Composecure, Inc. 309 Pierce Street Somerset NJ 08873 | Chief Product & Innov. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-08-14 | 45,000 | $4.31 | 1,337,219 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-08-14 | 45,000 | $11.06 | 1,292,219 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (Right to Buy) | Disposition | 2024-08-14 | 45,000 | $4.31 | 45,000 | $4.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 293,923 | 2030-06-14 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.13, inclusive. The reporting person undertakes to provide CompoSecure, Inc. (the "Issuer"), any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- Includes (A) 267,583 restricted stock units ("RSUs"), which will vest on January 1, 2025, (B) 267,583 RSUs, which will vest on January 1, 2026, and (C) 73,925 RSUs, which will vest on January 1, 2027. The RSUs will be settled into Class A Common Stock upon vesting and may be settled net of shares withheld to pay applicable taxes.
- Includes 130,976 performance-vesting RSUs, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into Class A Common Stock upon vesting.
- Includes 221,773 performance-vesting RSUs, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into Class A Common Stock upon vesting.
- All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Billionaire Hedge Funds
